Healthcare & Life Sciences
Lipum AB
Swedenlipum.se/eng/
Lipum AB is a Healthcare & Life Sciences startup based in Sweden, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Lipum AB
Based in Sweden, Lipum AB is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Lipum AB is a clinical-stage biotech company developing SOL-116, a humanized antibody targeting chronic inflammatory diseases such as rheumatoid arthritis, and has completed a Phase 1 clinical trial demonstrating safety and supporting further development.
Explore Lipum AB's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.